As of May 2026, BPC-157 remains on the FDAs Category 2 restricted list, pending advisory-committee review
Its not wise to use peptide therapy if you dont have a condition that may benefit from it
Once reconstituted, that stability window narrows significantly, which is why technique and storage are so important in research environments
Key Characteristics: Peptide Classification : Synthetic pentadecapeptide Sequence : GEPPPGKPADDAGLV (a partial sequence of human BPC) Bioactive Functions : Pro-angiogenic, anti-inflammatory, anti-fibrotic Stability : Highly stable in gastric juice (rare for peptides) Origin : Derived from a protein found in the stomachs protective lining Unlike most therapeutic peptides, BPC-157 is active both subcutaneously and orally , and does not require injection to achieve systemic effectsthough injections near the injury site offer superior localized outcomes
Table 3 lays out the computed numbers
Select your treatment Choose a plan that fits your needs and complete a medical intake form for review by providers